Benzinga - by Lisa Levin, Benzinga Editor.
Gainers
- VIQ Solutions Inc. (NASDAQ: VQS) shares rose 88.5% to $0.2470 in pre-market trading after falling 18% on Monday. VIQ Solutions recently announced delisting from the Nasdaq.
- Molekule Group, Inc. (NASDAQ: MKUL) shares gained 31.4% to $0.1960 in pre-market trading.
- AgileThought, Inc. (NASDAQ: AGIL) shares rose 28.8% to $0.2060 in pre-market trading after gaining 9% on
- Monday.
- ALX Oncology Holdings Inc. (NASDAQ: ALXO) shares rose 26.8% to $6.10 in pre-market trading after the company released interim Phase 2 data from its ASPEN-06 trial of evorpacept in advanced HER2-positive gastric cancer.
- SIGNA Sports United N.V. (NYSE: SSU) shares surged 22.9% to $0.1903 in pre-market trading after falling 44% on Monday. SIGNA Sports recently announced an acceleration of its strategic realignment and performance enhancement program.
- Loop Media, Inc. (NYSE: LPTV) rose 19.6% to $0.58 in pre-market trading.
- Renalytix Plc (NASDAQ: RNLX) rose 15.3% to $1.73 in pre-market trading after falling 6% on Monday. Renalytix recently reported worse-than-expected FY23 revenue results and issued FY24 guidance.
- MSP Recovery, Inc. (NASDAQ: LIFW) shares climbed 12.9% to $0.2260 in pre-market trading after falling around 7% on Monday.
- SeaStar Medical Holding Corporation (NASDAQ: ICU) gained 10.3% to $0.4601 in pre-market trading after jumping 58% on Monday. SeaStar Medical was recently granted Breakthrough Device Designation by the FDA for its Selective Cytopheretic Device for Cardiorenal Syndrome.
- Delta Apparel, Inc. (NYSE: DLA) shares jumped 8.1% to $7.12 in pre-market trading after the company said it received an unsolicited offer to purchase its Salt Life business.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Losers- AERWINS Technologies Inc. (NASDAQ: AWIN) fell 17.9% to $0.1880 in pre-market trading. AERWINS Technologies shares jumped around 90% on Monday after the company said it is considering strategic alternatives for its non-core operations.
- SmileDirectClub, Inc. (NASDAQ: SDC) fell 15.6% to $0.1360 in pre-market trading. SmileDirectClub received a written notice from Nasdaq that Nasdaq had determined that company's securities will be delisted from Nasdaq and suspended at opening of business on Oct. 4, 2023.
- Nisun International Enterprise Development Group Co., Ltd (NASDAQ: NISN) shares fell 15.6% to $2.00 in pre-market trading.
- Actelis Networks, Inc. (NASDAQ: ASNS) fell 13.6% to $1.08 in pre-market trading after gaining around 14% on Monday. Actelis recently announced it achieved Third Party Validation for FIPS cyber protection standard required by government agencies.
- NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) fell 10.3% to $0.2574 in pre-market trading after gaining 10% on Monday. NRx Pharmaceuticals announced FDA permission to proceed on Investigational New Drug application for NRX-101 to treat chronic pain.
- Eastside Distilling, Inc. (NASDAQ: EAST) fell 9.7% to $1.48 in pre-market trading after gaining 33% on Monday. The company recently announced the successful completion of a debt-for-equity exchange with key first and second lien debt holders.
- OpGen, Inc. (NASDAQ: OPGN) shares fell 9.6% to $0.3799 in pre-market trading after gaining 5% on Monday. OpGen recently requested to withdraw its registration statement on Form S-1.
- Better Choice Company Inc. (NYSE: BTTR) shares fell 9.6% to $0.1410 in pre-market trading after surging more than 25% on Monday.
- IceCure Medical Ltd (NASDAQ: ICCM) fell 8.9% to $0.7788 in pre-market. IceCure Medical shares jumped 54% on Monday after the company announced an independent study validated its ProSense cryoblation treatment as a safe and effective outpatient procedure for breast cancer with a 96.8% success rate.
- Femasys Inc. (NASDAQ: FEMY) fell 8% to $3.58 in pre-market trading after gaining more than 30% on Monday.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.